Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis
Yasushi Honda(Yokohama City University), Atsushi Nakajima(Yokohama City University)
Cited by 128
Related Papers
The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice
|PLoS ONE|2016|169
Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
|Scientific Reports|2016|83
Deficiency of iNOS-derived NO accelerates lipid accumulation-independent liver fibrosis in non-alcoholic steatohepatitis mouse model
|BMC Gastroenterology|2015|38
Inhibition of Peroxisome Proliferator-Activated Receptor γ Promotes Tumorigenesis Through Activation of the β-Catenin / T Cell Factor (TCF) Pathway in the Mouse Intestine
|Journal of Pharmacological Sciences|2008|12